The diagnosis and management of acute promyelocytic leukaemia (APML) in the context COVID‚Äê19 poses a challenge for clinicians. We present a case illustrating this due to the masking of the typical laboratory pattern of APML coagulopathy and the potential heightened risks of thrombosis and differentiation syndrome (DS) when the two conditions are combined.